Magnetic resonance imaging conditional pacemakers: Rationale, development and future directions

Indian Pacing and Electrophysiology Journal

Volumn 12, Issue 5, 2012, Pages 204-212

  Cronin, Edmond M ^a   Wilkoff, Bruce L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiovascular implantable electronic device (CIED); Implantable cardioverter defibrillator (ICD); Magnetic resonance imaging (MRI); Pacemaker

Indexed keywords

CLINICAL PROTOCOL; DEFIBRILLATOR; DEVICE APPROVAL; DEVICE SAFETY; ECONOMIC EVALUATION; ELECTROMAGNETIC FIELD; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PACEMAKER; PATIENT SAFETY; PATIENT SELECTION; RADIOFREQUENCY IDENTIFICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 84865820185     PISSN: None     EISSN: 09726292     Source Type: Journal    
DOI: 10.1016/S0972-6292(16)30543-5     Document Type: Review

References (42)

1. OECD.Stat [Internet]. Paris (France): Organisation for Economic Co-operation and Development; 2011 [cited Jan 02 2012]. Available from: http://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STAT.
2. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin. Electrophysiol. 2005:28;326-328.
3. Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R. Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin. Electrophysiol. 2001; 24:199-205.
4. Naehle CP, Meyer C, Thomas D, et al. Safety of brain 3-T MR imaging with transmitreceive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology 2008;249:991-1001.
5. Roguin A, Zviman MM, Meininger GR, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004; 110:475-482.
6. Shellock FG, Tkach JA, Ruggieri PM, Masaryk TJ. Cardiac pacemakers, ICDs, and loop recorder: evaluation of translational attraction using conventional ("long-bore") and "shortbore" 1.5- and 3.0-Tesla MR systems. J. Cardiovasc. Magn. Reson. 2003;5:387-397.
7. Sommer T, Vahlhaus C, Lauck G et al. MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology 2000;215:869-879.
8. Luechinger R, Zeijlemaker VA, Pedersen EM, et al. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur. Heart J. 2005;26:376-383.
9. Martin ET, Coman JA, Shellock FG et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J. Am. Coll. Cardiol. 2004;43:1315-1324.
10. Sommer T, Naehle CP, Yang A, et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 Tesla in the presence of cardiac pacemakers in nonpacemaker-dependent patients: a prospective study with 115 examinations. Circulation 2006;114:1285-1292.
11. Mollerus M, Albin G, Lipinski M, Lucca J. Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin. Electrophysiol. 2008;31:1241-1245.
12. Boilson BA, Wokhlu A, Acker NG, Felmlee JP, Watson Jr RE, Julsrud PR, Friedman PA, Cha YM, Rea RF, Hayes DL, Shen WK. Safety of magnetic resonance imaging in patients with permanent pacemakers: a collaborative clinical approach. J. Interv. Card. Electrophysiol. 2012;33:59-67.
13. Baser K, Guray U, Durukan M, Demirkan B. High ventricular lead impedance of a DDD pacemaker after cranial magnetic resonance imaging. Pacing Clin. Electrophysiol. 2011 Feb 8. doi:10.1111/j.1540-8159.2011.03027.x. [Epub ahead of print]
14. Anfinsen OG, Berntsen RF, Aass H, Kongsgaard E, Amlie JP. Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging. Pacing Clin.
15. Tandri H, Zviman MM, Wedan SR, Lloyd T, Berger RD, Halperin H. Determinants of gradient field-induced current in a pacemaker lead system in a magnetic resonance imaging environment. Heart Rhythm 2008;5:462-468.
16. Irnich W, Irnich B, Bartsch C, Stertmann WA, Gufler H, Weiler G. Do we need pacemakers resistant to magnetic resonance imaging? Europace 2005;7:353-365.
17. Gimbel JR. Unexpected asystole during 3T magnetic resonance imaging of a acemakerdependent patient with a 'modern' pacemaker. Europace 2009;11:1241-1242.
18. Achenbach S, Moshage W, Diem B, Bieberle T, Schibgilla V, Bachmann K. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am. Heart J. 1997;134:467-473.
19. Luechinger R, Duru F, Zeijlemaker VA, Scheidegger MB, Boesiger P, Candinas R. Pacemaker reed switch behavior in 0.5, 1.5, and 3.0 Tesla magnetic resonance imaging units: are reed switches always closed in strong magnetic fields? Pacing Clin. Electrophysiol. 2002;25:1419-1423.
20. Hayes DL, Holmes DR Jr, Gray JE. Effect of 1.5 Tesla nuclear magnetic resonance imaging scanner on implanted permanent pacemakers. J. Am. Coll. Cardiol. 1987;10:782-786.
21. Fetter J, Aram G, Holmes DR Jr, Gray JE, Hayes DL. The effects of nuclear magnetic resonance imagers on external and implantable pulse generators. Pacing Clin. Electrophysiol. 1984;7:720-727.
22. Vahlhaus C, Sommer T, Lewalter T, et al. Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5 Tesla? Pacing Clin. Electrophysiol. 2001;24:489-495.
23. Nazarian S, Roguin A, Zviman MM, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 Tesla. Circulation 2006;114:1277-1284.
24. Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann. Intern. Med. 2011;155:415-424.
25. Gimbel JR, Johnson D, Levine PA, Wilkoff BL. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin. Electrophysiol. 1996;19:913-19.
26. Cronin EM, Mahon N, Wilkoff BL. Magnetic resonance imaging in patients with cardiac implantable electronic devices. Expert Rev. Med. Devices 2012;9:139-146.
27. Luechinger R, Duru F, Scheidegger MB. Heating effects of magnetic resonance imaging of the brain on pacemaker leads: send/receive coils versus receive-only coil [abstr]. J. Am. Coll. Cardiol. 2001;37(suppl A):436A.
28. Mollerus M, Albin G, Lipinski M, Lucca J. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace 2010;12:947-951.
29. Langman DA, Goldberg IB, Finn JP, Ennis DB. Pacemaker lead tip heating in abandoned and pacemaker-attached leads at 1.5 Tesla MRI. J. Magn. Reson. Imaging 2011;33:426-431.
30. Goldsher D, Jahshan S, Roguin A. Successful cervical MR scan in a patient several hours after pacemaker implantation. Pacing Clin. Electrophysiol. 2009;32:1355-1356.
31. Gimbel JR. Unexpected pacing inhibition upon exposure to the 3T static magnetic field prior to imaging acquisition: what is the mechanism? Heart Rhythm 2011;8:944-945.
32. Cohen JD, Costa HS, Russo RJ. Determining the risks of MRI at 1.5-Tesla for patients with pacemakers and implantable cardioverter defibrillators (The MagnaSafe Registry). Circulation 2010;122:A21241.
33. Faris OP, Shein MJ. Government viewpoint: U.S. Food & Drug Administration: Pacemakers, ICDs and MRI. Pacing Clin. Electrophysiol. 2005;28:268-269.
34. Faris OP, Shein MJ. Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation 2006;114:1232-1233.
35. Wilkoff BL, Bello D, Taborsky M, et al. Magnetic resonance imaging in patients with a pacemaker system designed for the MR environment. Heart Rhythm 2011;8:65-73.
36. Biotronik SE & Co KG. Biotronik introduces the world's first and only implantable defibrillators eligible for magnetic resonance imaging. Berlin, Germany. November 23, 2011. Available at: http//Biotronik.com
37. Sasaki T, Hansford R, Zviman MM, et al. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverterdefibrillators. Circ. Cardiovasc. Imaging 2011;4:662-670.
38. Nazarian S, Halperin HR. How to perform magnetic resonance imaging on patients with implantable cardiac arrhythmia devices. Heart Rhythm 2009; 6: 138-143.
39. Naehle CP, Kreuz J, Strach K, et al. Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T. Am Heart J. 2011; 161: 1096-1105.
40. Hundley WG, Bluemke DA, Finn JP, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J. Am. Coll. Cardiol. 2010;55:2614-2662.
41. Shellock FG, Woods TO, Crues III JV. MRI labeling information for implants and devices: explanation of terminology. Radiology 2009;253:26-30.
42. Mitka M. First MRI-safe pacemaker receives conditional approval from FDA. J. Am Med. Assoc. 2011;305:985-986.